Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | PRKCA | P17252 | 2/20 | 0.32 |
| ▸ | NOS3 | P29474 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.32 |
| ▸ | NOS2 | P35228 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.31 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.31 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.31 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.30 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.30 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13850903 | 0.94 | ALDH1A1 (0.39) | ALDH1A1LMNAPRKCANOS3NOS1 | |
| SCHEMBL25515949 | 0.87 | NOS3 (0.31) | NOS3NOS1NOS2CA12CA1 | |
| SCHEMBL19152039 | 0.85 | ALDH1A1 (0.33) | ALDH1A1LMNAPRKCANOS3NOS1 | |
| SCHEMBL25515864 | 0.80 | CA1 (0.34) | NOS3NOS1NOS2CA12CA1 | |
| SCHEMBL24450210 | 0.80 | ALDH1A1 (0.65) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL19670823 | 0.78 | MAPT (0.40) | ALDH1A1PRKCANOS3NOS1NOS2 | |
| SCHEMBL4586536 | 0.78 | CA1 (0.37) | ALDH1A1NOS3NOS1NOS2CA12 | |
| SCHEMBL12261562 | 0.78 | CA1 (0.37) | LMNANOS3NOS1NOS2CA12 | |
| SCHEMBL25515999 | 0.78 | NOS3 (0.40) | NOS3NOS1NOS2CA12CA1 | |
| SCHEMBL18119724 | 0.77 | NOS3 (0.41) | NOS3NOS1NOS2CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159442-A1 | CELLULAR ENERGY COMPOUNDS, COMPOSITIONS, AND METHODS OF USE THEREOF | VIREO SYSTEMS, INC. (US) | 2023-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159442-A1 | CELLULAR ENERGY COMPOUNDS, COMPOSITIONS, AND METHODS OF USE THEREOF | PC, PCK2, MAVS | ALDH1A1 2051/4885LMNA 1859/4885PRKCA 167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.